A vascularized in vivo melanoma model suitable for metastasis research of different tumor stages using fundamentally different bioinks

Although 2D cancer models have been the standard for drug development, they don't resemble in vivo properties adequately. 3D models can potentially overcome this. Bioprinting is a promising technique for more refined models to investigate central processes in tumor development such as prolifera...

Full description

Bibliographic Details
Main Authors: Rafael Schmid, Sonja K. Schmidt, Stefan Schrüfer, Dirk W. Schubert, Stefanie Heltmann-Meyer, Martin Schicht, Friedrich Paulsen, Raymund E. Horch, Anja K. Bosserhoff, Annika Kengelbach-Weigand, Andreas Arkudas
Format: Article
Language:English
Published: Elsevier 2024-06-01
Series:Materials Today Bio
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2590006424001303